Daring to Make a Difference
Our Latest Products
Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.
Aesthetics
We are building the prestige market for aesthetics, comprised of expertly created products and services that are available exclusively in select practices who produce exceptional consumer experiences and outcomes.
Learn More
Therapeutics
We are evaluating therapeutic indications in muscle movement and pain disorders to meaningfully transform patient experiences.
Learn MoreFacts, Figures & Trends
Neuromodulators are the most performed minimally invasive cosmetic procedures, followed by dermal fillers 1
Explore Aesthetics
There are 12 Approved Therapeutic Indications for Botulinum Toxin Type A in the U.S. and hundreds of potential indications 2
Explore TherapeuticsStock Quote
$26.26
EXCHANGE
NYSE (US DOLLAR)
0.91
VOLUME
737,030
Price could be delayed by up to 15 mins
References
- The American Society of Plastic Surgeons. 2019 Plastic Surgery Statistic Report. Available at: https://www.plasticsurgery.org/documents/News/Statistics/2019/plastic-surgery-statistics-full-report-2019.pdf. Accessed July 2020
- Time Magazine, January 16, 2017, How BOTOX Became the Drug That’s Treating Everything. Available at: https://time.com/4623409/botox-drug-treating-everything/. Accessed April 2020
